A detailed history of Atlas Capital Advisors LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 10 shares of BDX stock, worth $2,292. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 2,860 99.65%
Holding current value
$2,292
Previous $697 Million 99.65%
% of portfolio
0.0%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$233.45 - $247.73 $665,332 - $706,030
-2,850 Reduced 99.65%
10 $2.47 Million
Q3 2021

Oct 28, 2021

SELL
$232.72 - $256.47 $46,311 - $51,037
-199 Reduced 6.51%
2,860 $685,000
Q2 2021

Jul 30, 2021

BUY
$232.65 - $254.58 $13,726 - $15,020
59 Added 1.97%
3,059 $725,000
Q2 2018

Jul 30, 2018

SELL
$208.1 - $233.85 $6,243 - $7,015
-30 Reduced 0.99%
3,000 $0
Q1 2018

Apr 18, 2018

BUY
$205.46 - $240.27 $622,543 - $728,018
3,030 New
3,030 $0

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.